Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Pyridorin in Diabetic Nephropathy
Phase 3
Terminated
- Conditions
- Diabetic NephropathyDiabetic Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2016-03-09
- Lead Sponsor
- NephroGenex, Inc.
- Target Recruit Count
- 328
- Registration Number
- NCT02156843
- Locations
- 🇺🇸
CSG Investigational Site (#157), Birmingham, Alabama, United States
🇺🇸CSG Investigational Site (#130), Phoenix, Arizona, United States
🇺🇸CSG Investigational Site (#150), Phoenix, Arizona, United States
Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetic Nephropathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- NephroGenex, Inc.
- Target Recruit Count
- 317
- Registration Number
- NCT00734253
- Locations
- 🇺🇸
The Collaborative Study Group, Chicago, Illinois, United States
News
No news found